新的治疗选择对于非常重要的世卫组织真菌优先病原体
Lisa Kriegl1, Matthias Egger1, Johannes Boyer2
1Division of Infectious Diseases, Department of Internal Medicine, ECMM Excellence Center for Clinical Mycology, Medical University of Graz, Graz, Austria; BioTechMed-Graz, Graz, Austria.
概括
像ibrexafungerp和rezafungin这样的新型抗真菌药物为对抗关键真菌感染提供了新的希望,解决了严重的全球健康威胁. 这些新兴的治疗方法为侵袭性真菌病和门诊护理提供了重要的替代方案.
科学领域:
- 医学真菌学 医学真菌学
- 传染性疾病 传染性疾病
- 药物开发 药物开发
背景情况:
- 真菌感染是全球主要的健康负担,与结核病和艾滋病毒相美.
- 世界卫生组织 (WHO) 确定了关键的真菌病原体,包括Aspergillus fumigatus,Candida albicans,Candida auris和Cryptococcus neoformans.
- 有限的治疗选择和新出现的耐药性挑战了有效的抗真菌治疗.
研究的目的:
- 对世卫组织优先的真菌病原体进行开发的新型抗真菌剂进行审查.
- 专注于最近的临床发现和新兴的治疗策略.
- 提供对侵入性真菌感染的新疗法选择的见解.
主要方法:
- 使用关键词对关键的真菌病原体和新型抗真菌物质进行了PubMed文献搜索.
- 包括对特定药物的搜索术语,如福斯曼诺格皮克斯,伊布雷克萨格尔普,奥特塞可纳和雷扎金.
- 专注于最近的临床数据和监管批准.
主要成果:
- 三种新的抗真菌药物 (ibrexafungerp,oteseconazole,rezafungin) 已经获得FDA的批准.
- 预计Olorofim和Fosmanogepix将很快获得批准,并在欧洲获得孤儿药物地位.
- 这些新型药物显示出对关键的真菌病原体有前途的临床疗效.
结论:
- 新的抗真菌药物如ibrexafungerp,rezafungin,fosmanogepix和olorofim为侵袭性真菌感染提供了有效的替代品.
- 这些药物可以改善住院和门诊患者的治疗结果.
- 持续的临床研究,管理和监测对于打击抗真菌耐药性和确保药物的安全性和有效性至关重要.
关键词:
这是一种抗真菌药物.亚斯伯吉拉斯烟虫 (Aspergillus fumigatus) 是一种有毒的植物.在Candida albicans中使用.它们是Candida auris.这是Cryptococcus neoformans的新型菌.福斯曼诺格皮克斯 (Fosmanogepix) 是一个古老的生物.在Ibrexafungerpp中使用侵袭性真菌感染 侵袭性真菌感染这种药物是Opelconazol.在Rezafungin中使用.更多相关视频
相关概念视频
01:28Pulmonary Tuberculosis V
179
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
179
01:28Pneumonia IV: Management
324
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
324
01:28International Nursing Organizations II
1.0K
The World Health Organization (WHO) is a specialized agency of the United Nations based in Geneva. The WHO has many initiatives that center around health. Primarily, they lead global efforts to expand universal health coverage using science-based policies and programs. They are also responsible for shaping health research agendas and developing norms and standards.
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
The WHO provides expert team support, including funding, vaccines, testing, and treatment tools at the country level to fight...
1.0K
01:29Pulmonary Tuberculosis I
242
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
242
01:20Infection
7.9K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
7.9K